Attention deficit/hyperactivity disorder: Is there a correlation between dopamine transporter density and cerebral blood flow?

Clinical Nuclear Medicine

Volumn 36, Issue 8, 2011, Pages 656-660

  Da Silva Jr , Neivo ^a,b   Szobot, Claudia M ^b,c   Anselmi, Carlos E ^a   Jackowski, Andrea P ^d   Chi, Shih M ^d   Hoexter, Marcelo Q ^d   Anselmi, Osvaldo E ^a   Pechansky, Flavio ^b   Bressan, Rodrigo A ^d   Rohde, Luis A ^e  

^a Laboratório de Medicina Nuclear Do Complexo Hospitalar Santa Casa LAMENU   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e Instituto Nacional de Psiquiatria do Desenvolvimento   (Brazil)

Author keywords

ADHD; cerebral blood flow; dopamine transporter; statistical parametric mapping; Tc 99m ECD; Tc 99m TRODAT 1

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; CYSTEINE ETHYL ESTER TC 99M; DOPAMINE TRANSPORTER; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; METHYLPHENIDATE; N (3 IODOPROPEN 2 YL) 2BETA CARBOMETHOXY 3BETA ( CHLOROPHENYL)TROPANE I 123; RADIOLIGAND; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN MAPPING; BRAIN PERFUSION; CEREBELLUM; CHILD; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DENSITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINERGIC SYSTEM; FEMALE; FRONTAL BONE; FRONTAL LOBE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MOLECULAR IMAGING; NEUROIMAGING; PARIETAL LOBE; SCHOOL CHILD; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBCORTEX; TEMPORAL LOBE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BASAL GANGLIA; CEREBROVASCULAR CIRCULATION; CYSTEINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MALE; NEOSTRIATUM; ORGANOTECHNETIUM COMPOUNDS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES; YOUNG ADULT;

EID: 79960226348     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318219b49d     Document Type: Article

References (30)

1. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164:942-948. (Pubitemid 46972911)
2. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1313-1323. (Pubitemid 40798551)
3. Feron FJ, Hendriksen JG, van Kroonenburgh MJ, et al. Dopamine transporter in attention-deficit hyperactivity disorder normalizes after cessation of meth-ylphenidate. Pediatr Neurol. 2005;33:179-183. (Pubitemid 41558215)
4. La Fougere C, Krause J, Krause KH, et al. Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder. Nucl Med Commun. 2006;27: 733-737. (Pubitemid 44213031)
5. Cook EH Jr, Stein MA, Krasowski MD, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 1995;56:993-998.
6. Krause J. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev Neurother. 2008;8:611-625. (Pubitemid 351551013)
7. Cheon KA, Ryu YH, Kim YK, et al. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging. 2003;30:306-311. (Pubitemid 36686852)
8. Choi JK, Chen YI, Hamel E, et al. Brain hemodynamic changes mediated by dopamine receptors: role of the cerebral microvasculature in dopamine-mediated neurovascular coupling. Neuroimage. 2006;30:700-712.
9. Lauritzen M. Relationship of spikes, synaptic activity, and local changes of cerebral blood flow. J Cereb Blood Flow Metab. 2001;21:1367-1383. (Pubitemid 33117178)
10. Logothetis NK. The underpinnings of the BOLD functional magnetic reso¬nance imaging signal. JNeurosci. 2003;23:3963-3971. (Pubitemid 36958412)
11. Jenkins BG, Sanchez-Pernaute R, Brownell AL, et al. Mapping dopamine function in primates using pharmacologic magnetic resonance imaging. J Neurosci. 2004;24:9553-9560. (Pubitemid 39441509)
12. Szobot CM, Rohde LA, Bukstein O, et al. Is attention-deficit/ hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study? Addiction. 2007;102:1122-1130. (Pubitemid 46918670)
13. Mercadante MT, Asbarch F, Rosário MC, et al. K-SADS. 1ed. São Paulo, Brazil SP: Protoc\Hospital das Clínicas da FMUSP; 1995.
14. Orvaschel H, Puig-Antich J. Schedule for Affective Disorders and Schizo¬phrenia for School-Age Children: Epidemiologic. 4th version. Ft Lauderdale, FL: Nova University, Center for Psychological Study; 1987.
15. Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40:168-179. (Pubitemid 32111020)
16. Wechsler D. Examiner's Manual: Wechsler Intelligence Scale for Children. 3rd ed. New York, NY: Psychological Corporation; 1991.
17. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of Human Brain. New York, NY: Stuttgart Thieme; 1988.
18. Busatto GF, Zamignani DR, Buchpiguel CA, et al. A voxel-based investiga¬tion of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Res. 2000;99:15-27. (Pubitemid 30417413)
19. Krause J, la Fougere C, Krause KH, et al. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. Eur Arch Psychiatry Clin Neurosci. 2005;255:428-431. (Pubitemid 43029831)
20. Krause KH, Dresel SH, Krause J, et al. Increased striatal dopamine trans¬porter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomogra¬phy. Neurosci Lett. 2000;285:107-110. (Pubitemid 30227631)
21. Dresel S, Krause J, Krause KH, et al. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med. 2000;27:1518-1524.
22. Ingvar M, Lindvall O, Stenevi U. Apomorphine-induced changes in local cerebral blood flow in normal rats and after lesions of the dopaminergic nigrostriatal bundle. Brain Res. 1983;262:259-265. (Pubitemid 13148314)
23. Logan J, Volkow ND, Fowler JS, et al. Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab. 1994;14:995-1010.
24. Erlandsson K, Bressan RA, Mulligan RS, et al. Kinetic modelling of [123I]CNS 1261\a potential SPET tracer for the NMDA receptor. Nucl Med Biol. 2003;30:441-454. (Pubitemid 36589052)
25. Gustafsson P, Thernlund G, Ryding E, et al. Associations between cerebral blood-flow measured by single photon emission computed tomography (SPECT), electro-encephalogram (EEG), behaviour symptoms, cognition and neurological soft signs in children with attention-deficit hyperactivity disorder (ADHD). Acta Paediatr. 2000;89:830-835. (Pubitemid 30622584)
26. Kaya GC, Pekcanlar A, Bekis R, et al. Technetium-99m HMPAO brain SPECT in children with attention deficit hyperactivity disorder. Ann Nucl Med. 2002;16:527-531. (Pubitemid 36205669)
27. Kim BN, Lee JS, Shin MS, et al. Regional cerebral perfusion abnormalities in attention deficit/hyperactivity disorder. Statistical parametric mapping anal¬ysis. Eur Arch Psychiatry Clin Neurosci. 2002;252:219-225.
28. Szobot CM, Shih MC, Schaefer T, et al. Methylphenidate DAT binding in adolescents with Attention-Deficit/Hyperactivity Disorder comorbid with Substance Use Disorder\a single photon emission computed tomography with [Tc(99m)] TRODAT-1 study. Neuroimage. 2008;40:1195-1201.
29. Szobot CM, Ketzer C, Cunha RD, et al. The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder. Eur J Nucl Med Mol Imaging. 2003;30:423-426. (Pubitemid 36692869)
30. Kim BN, Lee JS, Cho SC, et al. Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder. Yonsei Med J. 2001;42:19-29